Background
==========

Nocardiosis is a rare infection which primarily occurs in the setting of immunocompromising conditions such as human immunodeficiency virus (HIV) infection, transplantation, malignancy, and steroid or immunosuppressive therapy \[[@b1-poljradiol-80-13]--[@b6-poljradiol-80-13]\]. However, up to one third of the patients may be immunocompetent \[[@b7-poljradiol-80-13]\].

The lungs are the most common site of nocardiosis \[[@b1-poljradiol-80-13],[@b7-poljradiol-80-13]\]. Clinical and radiological manifestations of pulmonary nocardiosis are nonspecific and definite microbiological data are lacking for most *nocardia* species. Therefore, this disease may be underestimated.

Chest radiograph is the first imaging study and shows nonspecific findings such as pulmonary nodules, consolidation, cavity, pulmonary infiltrations and pleural effusion \[[@b5-poljradiol-80-13],[@b6-poljradiol-80-13],[@b8-poljradiol-80-13]--[@b10-poljradiol-80-13]\]. Although, computed tomography (CT) shows more detailed features \[[@b1-poljradiol-80-13]--[@b4-poljradiol-80-13],[@b11-poljradiol-80-13],[@b12-poljradiol-80-13]\], no specific pattern has been yet reported on and also there is no study comparing CT presentations of pulmonary nocardiosis between immunocompromised and immunocompetent patients. Achieving a dominant CT presentation pattern for pulmonary nocardiosis could be helpful to prompt the diagnosis, decrease the morbidity and mortality, especially in immunocompromised patients, as well as to obviate the need for biopsy.

Material and Methods
====================

Twenty-five consecutive patients (mean age 39.5±17 years; 76% male) with proven pulmonary nocardiosis (by CT-guided lung biopsy \[n=8\] or bronchoalveolar lavage \[n=17\]) who were admitted to a tertiary center for lung diseases from March 2001 to March 2011 were included in the study. Patients with co-infections (including two cases of tuberculosis) were excluded. None of the patients had pneumonia or primary or metastatic lung cancer.

Fourteen patients (56%) were immunocompetent and 11 cases (44%) had underlying immunosuppressive conditions, including chronic granulomatous disease (CGD) (n=4), diabetes mellitus (DM) (n=2), malignancy (n=2), HIV (n=1), concomitant CGD and DM (n=1), and steroid therapy for nephrotic syndrome (n=1). There were no significant differences between immunocompromised and immunocompetent patients with regard to age (mean age: 42.5 *vs.* 35.5 years, respectively; *p*\>0.05) and sex (90% *vs.* 70% males, respectively; *p*\>0.05).

Chest CT was performed using a 16-slice multi-detector CT scanner (SOMATOM Definition Flash, Siemens Healthcare, Forchheim, Germany). Image acquisition was spaced from the lung apex to the base (1.5--3-mm collimation at 10-mm intervals) with scan parameters of 120 kVp, 200 mA and scan duration of 3 seconds. All chest CT images were reviewed by two expert pulmonary radiologists with 17 and 10 years of experience with almost perfect interobserver agreement (kappa=.81). The radiologists were blinded to the medical history and clinical status of the patients.

The comparison between subgroups was performed by SPSS version 17.0 (SPSS, Inc., Chicago, IL) using Chi^2^ and Fisher's exact test. A *p*-value of less than 0.05 was considered significant.

Results
=======

All CT findings of pulmonary nocardiosis and comparison of immunocompromised and immunocompetent patients are summarized in [Table 1](#t1-poljradiol-80-13){ref-type="table"}. There was no statistically significant difference in the CT findings of immunocompromised and immunocompetent groups. Although the cavity/cavitary consolidation in the immunocompromised patients (72.7%) was more common than in immunocompetent patients (35.7%), that difference was not statistically significant.

In overall, the most common CT finding was pulmonary nodules (96%) ([Figures 1](#f1-poljradiol-80-13){ref-type="fig"} and [2](#f2-poljradiol-80-13){ref-type="fig"}). All pulmonary nodules were multiple (ranging from 3 nodules to bilateral diffuse nodules). The size of fifty-two percent of nodules was \<3 mm and 48% were of ≥3 mm in size. Cavitary nodules were seen in two patients and tree-in-bud pattern was seen in another two cases. The distribution of pulmonary nodules was as follows: bilateral diffuse nodules in 40%, single lobe in 32% (most common in the left lower lobe, 16%), and bi-lobe involvement in 24% (most common in bilateral upper lobes, 16%). All cavitary and tree-in-bud nodules were seen in female patients, while none of male patients had cavitary or tree-in-bud nodules (*p*=0.003).

The second most common CT finding was lung consolidation (76%, including 52% of cavitary consolidation) ([Figures 2](#f2-poljradiol-80-13){ref-type="fig"} and [3](#f3-poljradiol-80-13){ref-type="fig"}). More than half (58%) of consolidations were bilateral and multifocal. Single lobe consolidation was seen in five cases, all in the right upper lobe. Thirteen out of 19 lung consolidations were cavitary consolidation, and five cases were mass-like consolidation.

Bronchiectasis was the third CT finding with a frequency of 40%. Seventy-five percent of patients with bronchiectasis had single lobe involvement with a relatively similar distribution in bilateral upper and lower lobes. The mean age of the patients with bronchiectasis was significantly higher than that of patients without bronchiectasis (46.5±11.8 *vs.* 33±13 years; *p*=0.04).

The ground glass opacities were seen in about one third (32%) of the patients and showed nonspecific distribution.

Pleural thickening (40%) was seen predominantly as bilateral multifocal irregular thickening ([Figure 4](#f4-poljradiol-80-13){ref-type="fig"}). All three pleural effusions (12%) were unilateral.

Discussion
==========

Pulmonary nocardiosis most often presents as an opportunistic infection in patients with underlying immunodeficiency/immunosuppressive conditions \[[@b1-poljradiol-80-13]--[@b6-poljradiol-80-13]\]. Previous studies showed that up to one third of these patients can be healthy immunocompetent individuals \[[@b7-poljradiol-80-13]\]. That rate was higher in our series and more than half (56%) of cases was immunocompetent patients. Although the presence of an immunocompromising condition in patients with lung consolidations or nodules on CT may suggest an opportunistic organism, a significant portion of patients with nocardiosis may not have such a condition. Therefore, finding a specific radiologic presentation may be helpful for diagnosing pulmonary nocardiosis.

To the best of our knowledge, there is no previous comprehensive study comparing CT presentations of pulmonary nocardiosis between immunocompromised and immunocompetent patients. Only Blackmon et al. \[[@b1-poljradiol-80-13]\] in their review of CT features of pulmonary nocardiosis found discrete nodules to be more often associated with immunosuppression. In that study, we did not find any significant difference between immunocompromised and immunocompetent patients. The main CT pattern of pulmonary nocardiosis in both immunocompromised and immunocompetent patients in our study was a combination of pulmonary nodules, consolidation and cavity. That was relatively similar to the results of the previous studies; for example, in the study by Blackman et al., consolidation was the most common (64.2%) presentation of nocardiosis, followed by pulmonary nodules (57%) and cavity (40%) \[[@b1-poljradiol-80-13]\]. Consolidation, pulmonary nodules and masses were also common CT features of nocardiosis in the study by Kanne et al. Cavitation was also seen in some cases \[[@b12-poljradiol-80-13]\]. In another study, on 24 patients with nocardiosis, the most common CT findings were single or multiple pulmonary nodules and masses (83%). Other findings were cavity (33%), consolidation (33%) and pleural thickening (29%) \[[@b3-poljradiol-80-13]\]. In overall, based on our study and previous studies \[[@b2-poljradiol-80-13],[@b3-poljradiol-80-13],[@b5-poljradiol-80-13],[@b6-poljradiol-80-13],[@b11-poljradiol-80-13],[@b12-poljradiol-80-13]\], in CT images which show lung consolidations, nodules, masses (or mass-like consolidation), and cavity, pulmonary nocardiosis can be suggested, especially in the setting of immunocompromising conditions.

The incidence of some less common findings in the present study was different from the one in the previous studies; pleural effusion was seen in 8% of our patients, while its frequency reached 80% in the study by Yoon et al. \[[@b11-poljradiol-80-13]\] and 75% in the study by Raby et al. \[[@b6-poljradiol-80-13]\]. Cavity (12.5%) and pulmonary nodules (37.5%) in the study by Raby et al. \[[@b6-poljradiol-80-13]\] were considerably less frequent than in our study (52% and 96%, respectively). The differences between our findings and the two mentioned studies may be due to the limited number of patients in those studies; there were only five patients in Yoon et al. study \[[@b11-poljradiol-80-13]\], and eight patients in Raby et al. study \[[@b6-poljradiol-80-13]\].

Bronchiectasis and ground glass opacities were the relatively common findings in the present study, whereas they were not reported or reported with considerably lower frequencies in other studies \[[@b1-poljradiol-80-13],[@b3-poljradiol-80-13],[@b6-poljradiol-80-13],[@b11-poljradiol-80-13]\]. Interstitial involvement in Blackman et al. study (38%) \[[@b1-poljradiol-80-13]\] was significantly higher than in our study.

Although, based on our and other studies, consolidation, nodules, masses, and cavity are the main CT presentations of pulmonary nocardiosis, these findings may also be seen in the other conditions, such as tuberculosis, invasive aspergillosis, other pneumonias, and lung cancer \[[@b13-poljradiol-80-13]--[@b20-poljradiol-80-13]\]. For example, in the studies by Cha et al. \[[@b13-poljradiol-80-13]\], Yoem et al. \[[@b14-poljradiol-80-13]\], Chung et al. \[[@b15-poljradiol-80-13]\], and Kim et al. \[[@b16-poljradiol-80-13]\], pulmonary nodules, consolidation, and cavity were the most common features of tuberculosis. Not only are the radiological findings of pulmonary nocardiosis and other conditions (especially tuberculosis or invasive pulmonary aspergillosis) similar, these diseases occur mostly in the setting of underlying immunocompromising conditions. This is a diagnostic challenge. With respect to lower prevalence of nocardiosis in comparison to other mentioned diseases, it will be very difficult to suggest nocardiosis at the top of the list of differential diagnoses. Therefore, the mentioned findings are not specific and do not obviate the need for additional diagnostic tests, especially in immunodeficient patients.

Conclusions
===========

Pulmonary nocardiosis has similar CT presentations in both immunocompromised and immunocompetent patients, which mainly consist of co-existing multiple pulmonary nodules, consolidations, and cavity. However, the findings are more suggestive of nocardiosis in the setting of an underling immunocompromised condition.
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![Bilateral pulmonary nodules of a different size in a 60-year-old diabetic man with pulmonary nocardiosis.](poljradiol-80-13-g001){#f1-poljradiol-80-13}

![Cavitary consolidation in a 51-year-old HIV-positive woman with pulmonary nocardiosis.](poljradiol-80-13-g002){#f2-poljradiol-80-13}

![Bilateral cavitary consolidation and cavitary nodules in a 59-year-old man who presented with cough, fever and weight loss. Bronchoalveolar lavage revealed nocardiosis. Mild pleural effusion is also evident on the left side.](poljradiol-80-13-g003){#f3-poljradiol-80-13}

![Bilateral irregular pleural thickenig in a 39-year-old man with chronic granulomatous disease. Pulmonary nocardiosis was diagnosed by CT-guided biopsy.](poljradiol-80-13-g004){#f4-poljradiol-80-13}

###### 

Frequency (%) of CT findings in patints with pulmonary nocardiosis.

                                                      Nodules   Consolidation   Cavity   Bronchiectasis   Pleural thickening   Pleural effusion   Ground glass opacity   Lmphadenopathy   Reticular pattern   Pericardial effusion   p value
  -------------------------- ------------------------ --------- --------------- -------- ---------------- -------------------- ------------------ ---------------------- ---------------- ------------------- ---------------------- -----------------------------------------------------------
  Gender                     Male (n=19)              94.7      79              52.6     52.6             31.6                 10.5               36.8                   13.8             5.3                 0.0                    \>0.05[\*](#tfn1-poljradiol-80-13){ref-type="table-fn"}
  Female (n=6)               100                      66.7      50              33.3     66.7             16.7                 16.7               16.7                   0.0              16.7                                       
  Age group                  20--40 (n=4)             100       88.2            65       29.4             35.3                 5.9                53.3                   11.8             0.0                 0.0                    \>0.05[\*\*](#tfn2-poljradiol-80-13){ref-type="table-fn"}
  41--60 (n=17)              75                       50        25              100      25               25                   25                 25                     25               0.0                                        
  ≥61 (n=4)                  100                      50        25              75       75               25                   25                 25                     0.0              25                                         
  Immunity status            Immunocompetent (n=14)   93        91              72.7     57.1             35.7                 14.2               45.5                   7                7                   7                      \>0.05
  Immunocompromised (n=11)   100                      64.3      35.7            34.6     45.5             0                    27.3               27                     0                0                                          
  Total (n=25)                                        96        76              52       48               40                   12                 32                     16               4                   4                      

There was no cavitary or tree-in-bud pulmonary nodules in the male patients, while both type of nodules were seen in 33% of the females (*p*=0.003);

The mean age of patients with bronchiectasis was significantly higher than that of patients without bronchiectasis (46.5±11.8 *vs.* 33±13 year; *p*=0.04).
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